Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | Russell 2000® |
| Investment focus | Equity, United States, Small Cap |
| Fund size | GBP 177 m |
| Total expense ratio | 0.35% p.a. |
| Replication | Synthetic (Unfunded swap) |
| Legal structure | ETF |
| Investment approach | Long-only |
| Sustainability | No |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in GBP) | 17.92% |
| Inception/ Listing Date | 7 January 2014 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Luxembourg |
| Fund Provider | Amundi ETF |
| Fund Structure | Company With Variable Capital (SICAV) |
| UCITS compliance | Yes |
| Administrator | CACEIS Bank, Luxembourg Branch |
| Investment Advisor | |
| Custodian Bank | CACEIS Bank, Luxembourg Branch |
| Revision Company | PWC |
| Fiscal Year End | 30 September |
| Swiss representative | CACEIS (Switzerland) SA |
| Swiss paying agent | CACEIS Bank, Paris, succursale de Nyon / Suisse |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Non-Tax Reporting Fund |
| UK | UK Reporting |
| Italy | 26.0% |
| Indextype | Total return index |
| Swap counterparty | BNP Paribas |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty |
| JFrog | 0.34% |
| Moog | 0.34% |
| UMB Financial | 0.34% |
| Glaukos | 0.33% |
| Brinker International | 0.32% |
| BrightSpring Health Svcs | 0.31% |
| Cytokinetics | 0.30% |
| Twist Bioscience | 0.29% |
| Krystal Biotech | 0.29% |
| FirstCash Holdings | 0.29% |
| United States | 95.11% |
| Bermuda | 1.66% |
| Other | 3.23% |
| Finance | 26.35% |
| Healthcare | 20.72% |
| Technology | 11.75% |
| Industrials | 10.38% |
| Other | 30.80% |
| YTD | +12,24% |
| 1 mes | -3,96% |
| 3 meses | -6,48% |
| 6 meses | +0,65% |
| 1 año | +13,53% |
| 3 años | +50,52% |
| 5 años | +31,28% |
| Desde el inicio (MAX) | +228,89% |
| 2025 | +4,43% |
| 2024 | +12,80% |
| 2023 | +10,26% |
| 2022 | -11,17% |
| Volatilidad 1 año | 17,92% |
| Volatilidad 3 años | 21,31% |
| Volatilidad 5 años | 22,83% |
| Rentabilidad por riesgo 1 año | 0,76 |
| Rentabilidad por riesgo 3 años | 0,68 |
| Rentabilidad por riesgo 5 años | 0,24 |
| Pérdida máxima 1 año | -10,60% |
| Pérdida máxima 3 año | -28,81% |
| Pérdida máxima 5 año | -28,81% |
| Pérdida máxima desde el inicio | -37,16% |
| Listado | Divisa | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | 18MR | - - | - - | - |
| Euronext Paris | USD | RS2U | RS2U FP IRS2U | RS2U.PA IRS2U=BNPP | BNP Paribas Arbitrage |
| London Stock Exchange | GBX | RS2G | RS2G LN IRS2U | RS2G.L IRS2UINAV.PA | BNP Paribas Arbitrage |
| London Stock Exchange | USD | RS2U | RS2U LN IRS2U | RS2U.L IRS2U=BNPP | BNP Paribas Arbitrage |
| SIX Swiss Exchange | USD | RS2U | RS2U SW IRS2U | RS2U.S IRS2U=BNPP | BNP Paribas Arbitrage |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF USD | 4,061 | 0.30% p.a. | Accumulating | Sampling |
| Xtrackers Russell 2000 UCITS ETF 1C | 1,899 | 0.30% p.a. | Accumulating | Full replication |
| Invesco Russell 2000 UCITS ETF Acc | 283 | 0.25% p.a. | Accumulating | Swap-based |
| iShares Russell 2000 Swap UCITS ETF USD (Acc) | 47 | 0.20% p.a. | Accumulating | Swap-based |
| Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD Acc | 12 | 0.20% p.a. | Accumulating | Full replication |